|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.53 HKD | -0.39% |
|
+0.80% | +1.61% |
Essex Bio-Technology Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 655.83 million compared to HKD 737.37 million a year ago. Net income was HKD 139.23 million compared to HKD 162.19 million a year ago.
Basic earnings per share from continuing operations was HKD 0.2421 compared to HKD 0.2812 a year ago. Diluted earnings per share from continuing operations was HKD 0.2352 compared to HKD 0.2738 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.61% | 185M | |
| -3.15% | 89.69B | |
| +3.95% | 41.34B | |
| -10.51% | 33.72B | |
| +58.49% | 26.11B | |
| -20.09% | 14.63B | |
| -8.92% | 12.84B | |
| -11.46% | 11.66B | |
| -43.05% | 11.52B | |
| +4.57% | 8.92B |
ESSEX BIO-TECHNOLOGY LIMITED 